PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs

OBJECTIVE: Epidermal growth factor receptor (EGFR) activation was reported to upregulate programmed death-ligand 1 (PD-L1) expression in lung cancer cells and subsequently contribute to immune escape, indicating its critical role in EGFR-driven lung tumors. This study characterized PD-L1 expression...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Biol Med
Главные авторы: Bai, Yuchen, Chen, Xiaoxia, Hou, Likun, Qian, Jun, Jiang, Tao, Zhou, Caicun, Ciebiada, Maciej
Формат: Artigo
Язык:Inglês
Опубликовано: Chinese Anti-Cancer Association 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372913/
https://ncbi.nlm.nih.gov/pubmed/30766753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2018.0223
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы